Business Wire09.10.19
The Medical Device Innovation Consortium (MDIC) has recruited Jon Hunt, Ph.D., as vice president of Clinical Science & Technology. In this role, Hunt will facilitate efforts between the Consortium and its partners to identify ways to reduce costs, speed time to market, document efficacy and safety of medical devices, and provide oversight for regulatory science initiatives. He joins MDIC following his most recent tenure leading the clinical affairs and regulatory programs for Cryterion Medical, makers of cryoablation platform for atrial fibrillation that was acquired last year by Boston Scientific.
“We are extremely pleased to have Jon join the MDIC team,” said Pamela Goldberg, president and CEO of MDIC. “Jon’s history of innovation, coupled with his passion for improving regulatory science, will complement and strengthen the team we already have in place. We look forward to his leadership as we build on prior successes in early feasibility studies, clinical diagnostics, and the science of patient input.”
Hunt brings extensive experience driving clinical and regulatory programs for medical devices. Before his time with Cryterion Medical, he served as president and CEO of Bardy Diagnostics, whose ECG monitoring system achieved U.S. and European approval under his leadership. His prior work includes more than 20 years of leadership in general management, clinical and regulatory affairs, and sales and marketing in a broad range of successful medical technology companies. Hunt earned his Ph.D. in motor control from Pennsylvania State University, his master of arts degree in motor control from California State University, and his bachelor of science degree from Keele University in Staffordshire, England.
"I have spent my entire career developing, evaluating and bringing new cardiovascular medical devices to market,” said Hunt. “I am excited to join the MDIC team to support their mission to improve the development and assessment of new medical technologies resulting in safer and more cost-effective solutions for patient benefit.”
Founded in 2012, the Medical Device Innovation Consortium (MDIC) is the first public-private partnership created with the sole objective of advancing medical device regulatory science throughout the total product life cycle. MDIC’s mission is to promote public health through science and technology and to enhance trust and confidence among stakeholders. MDIC works in the pre-competitive space to facilitate the development of methods, tools, and approaches that enhance understanding and improve evaluation of product safety, quality, and effectiveness. Its initiatives aim to improve product safety and patient access to cutting-edge medical technology while reducing cost and time to market.
“We are extremely pleased to have Jon join the MDIC team,” said Pamela Goldberg, president and CEO of MDIC. “Jon’s history of innovation, coupled with his passion for improving regulatory science, will complement and strengthen the team we already have in place. We look forward to his leadership as we build on prior successes in early feasibility studies, clinical diagnostics, and the science of patient input.”
Hunt brings extensive experience driving clinical and regulatory programs for medical devices. Before his time with Cryterion Medical, he served as president and CEO of Bardy Diagnostics, whose ECG monitoring system achieved U.S. and European approval under his leadership. His prior work includes more than 20 years of leadership in general management, clinical and regulatory affairs, and sales and marketing in a broad range of successful medical technology companies. Hunt earned his Ph.D. in motor control from Pennsylvania State University, his master of arts degree in motor control from California State University, and his bachelor of science degree from Keele University in Staffordshire, England.
"I have spent my entire career developing, evaluating and bringing new cardiovascular medical devices to market,” said Hunt. “I am excited to join the MDIC team to support their mission to improve the development and assessment of new medical technologies resulting in safer and more cost-effective solutions for patient benefit.”
Founded in 2012, the Medical Device Innovation Consortium (MDIC) is the first public-private partnership created with the sole objective of advancing medical device regulatory science throughout the total product life cycle. MDIC’s mission is to promote public health through science and technology and to enhance trust and confidence among stakeholders. MDIC works in the pre-competitive space to facilitate the development of methods, tools, and approaches that enhance understanding and improve evaluation of product safety, quality, and effectiveness. Its initiatives aim to improve product safety and patient access to cutting-edge medical technology while reducing cost and time to market.
